MicroRNA-501 Promotes HBV Replication by Targeting HBXIP

Jiang Jin,Shanhong Tang,Lin Xia,Rui Du,Huahong Xie,Jiugang Song,Rui Fan,Qian Bi,Zheng Chen,Guitao Yang,Jie Liu,Yongquan Shi,Daiming Fan

DOI: https://doi.org/10.1016/j.bbrc.2012.12.071

IF: 3.1

2013-01-01

Biochemical and Biophysical Research Communications

Abstract:MicroRNAs (miRNAs) can negatively regulate gene expression and also induce or inhibit viral replication. In the present study, we found 10 miRNAs were differentially expressed in a stable HBV-producing cell line (HepG2.2.15) compared with its control cell line (HepG2) by miRNA array analysis. miR-501 was significantly up-regulated in HepG2 cells and tissues with high-HBV replication. miR-501 expression was significantly up-regulated in hepatocellular carcinoma tissues, where HBV replication kept high. Down-regulating miR-501 could significantly inhibit HBV replication, but not influence the growth of HepG2.2.15 cells. Luciferase reporter and western blot assays revealed that HBXIP, an inhibitor of HBV replication, was a potential target of miR-501. Moreover, knockdown of HBXIP rescued the inhibition of HBV that occurred after the loss of miR-501 in HepG2.2.15 cells, suggesting that miR-501 induced HBV replication partially by targeting HBXIP. Thus, knockdown of miR-501 might provide a new mechanism and therapeutic target for inhibiting HBV replication.